Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;16 Suppl 2(Suppl 2):S14.
doi: 10.1186/1471-2164-16-S2-S14. Epub 2015 Jan 21.

Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility

Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility

Chakshu Vats et al. BMC Genomics. 2015.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ribbon representation of the superimposition of structures of the native and mutant M. tuberculosis PncA protein.
Figure 2
Figure 2
Depiction of hydrogen bond interactions in A) native protein bound to PZA after docking, B) native protein bound with PZA after MD simulations, C) docked mutant PncA-PZA complex, D) mutant protein bound to PZA post MD simulations.
Figure 3
Figure 3
Hydrophobic interaction pattern in A) native protein bound to PZA after docking, B) native protein bound with PZA after MD simulations, C) docked mutant PncA-PZA complex, D) mutant protein bound to PZA post MD simulations.
Figure 4
Figure 4
Graph showing the RMSD of backbone of native unbound protein, native bound to PZA, mutant protein in unbound form and mutant protein in complex with PZA.
Figure 5
Figure 5
Radius of gyration of native and mutant protein in complex with PZA.
Figure 6
Figure 6
Root mean square fluctuation of all the residues in native protein bound to PZA, mutant protein in unbound form and mutant protein in complex with PZA.

References

    1. Onyango RO. State of the Globe: Tracking Tuberculosis is the Test of Time. J Glob Infect Dis. 2011;3(1):1–3. doi: 10.4103/0974-777X.77287. - DOI - PMC - PubMed
    1. McQuade Billingsley K, Smith N, Shirley R, Achieng L, Keiser P. A quality assessment tool for tuberculosis control activities in resource limited settings. Tuberculosis. 2011;91(Suppl 1):S49–53. - PMC - PubMed
    1. Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 1999;3(7):564–581. - PubMed
    1. Dooley KE, Mitnick CD, Ann DeGroote M, Obuku E, Belitsky V, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N. et al.Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;55(4):572–581. doi: 10.1093/cid/cis487. - DOI - PMC - PubMed
    1. Dhiman H, Dhanjal JK, Sharma S, Chacko S, Grover S, Grover A. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B. Biochem Biophys Res Commun. 2013;433(4):552–557. doi: 10.1016/j.bbrc.2013.03.013. - DOI - PubMed

Publication types

MeSH terms